Key result
Higher plasma PCSK9 correlates with elevated sdLDL overall, but loses significance in diabetes.
Cohort (n=1,766)
No
Answers are grounded in this paper and cite their sources.
Cohort study finds plasma PCSK9 correlates with small dense LDL in the general population but not in diabetic individuals after adjustment, suggesting distinct lipid regulation in diabetes.
This study aimed to investigate the relationship between plasma proprotein convertase subtilisin kexin 9 (PCSK9) and small dense low-density lipoprptein (sdLDL) in diabetic and non-diabetic participants in a community-dwelling cohort.The plasma levels of PCSK9 and sdLDL were detected in 1766 participants (median age: 61.40 years; 733 males vs 1033 females; 383 diabetic vs 1383 non-diabetic patients) from the Pingguoyuan community of Beijing, China.Results showed that Pearson correlation analysis revealed a positive correlation between PCSK9 and sdLDL (r = 0.263, P < .001). Multiple linear regression analysis showed a significant positive correlation between plasma PCSK9 and sdLDL in the whole population study. sdLDL was used as the dependent variable, and the potential cofounders were adjusted. However, any independent relationship was not observed between circulating PCSK9 and sdLDL in the diabetic subpopulation (r = 0.269, P < .05, β = 9.591, P > .05).Thus, there is a positive correlation between plasma PCSK9 and sdLDL in a community-dwelling cohort, but not in type 2 diabetic subpopulation, after confounder adjustment.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2019) conducted a cohort in Type 2 diabetes and dyslipidemia (sdLDL) (n=1,766). Plasma PCSK9 levels vs. Diabetic vs non-diabetic subpopulation was evaluated on Plasma small dense low-density lipoprotein (sdLDL) levels (r = 0.263, p=<.001). Plasma PCSK9 positively correlated with sdLDL in a community-dwelling cohort, but not in the diabetic subpopulation after confounder adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: